Mangadu, Ruban
Merck & Co., Inc., Rahway, NJ, USA (United States)
3 papers on CoChat
Most cited papers
- Verified
Targeted degradation of PCNA outperforms stoichiometric inhibition to result in programed cell death
Chang, S. C., Gopal, P., Lim, S., Wei, X., Chandramohan, A., Mangadu, R., Smith, J., Ng, S., Gindy, M., Phan, U., et al. (2022) · Cell Chemical Biology
Protein Degradation and InhibitorsUbiquitin and proteasome pathways
Cited by 31
- Verified
Targeted degradation of PCNA outperforms stoichiometric inhibition to result in programed cell death
Chang, S. C., Gopal, P., Lim, S., Wei, X., Chandramohan, A., Mangadu, R., Smith, J., Ng, S., Gindy, M., Phan, U., et al. (2022) · Cell chemical biology
Protein Degradation and InhibitorsUbiquitin and proteasome pathways
Cited by 31
- Verified
In vivo anti-tumor efficacy of afucosylated anti-CS1 monoclonal antibody produced in glycoengineered Pichia pastoris
Gomathinayagam, S., Laface, D., Houston-Cummings, N. R., Mangadu, R., Moore, R., Shandil, I., Sharkey, N., Li, H., Stadheim, T. A., & Zha, D. (2015) · Journal of Biotechnology
Monoclonal and Polyclonal Antibodies ResearchGlycosylation and Glycoproteins Research
Cited by 9
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free